Spectral AI Inc
Spectral AI operates with a cash balance of $15.4 million against $27.1 million in total liabilities, resulting in a negative equity position of $5.7 million. The company's liquidity position is rated as low, with a current ratio of 0.94 and negative free cash flow of $7.5 million in the latest period. The enterprise value to revenue multiple of 3.09 suggests market optimism despite the company's negative EBITDA of $7.57 million. The company's financial performance shows significant underperformance relative to industry norms. With a return on equity of 1.32% and a negative return on assets of -0.35%, Spectral AI lags behind the typical performance metrics for advanced medical equipment firms. The operating margin of -43.8% (calculated from $8.6 million operating loss on $19.7 million revenue) indicates structural cost challenges. Geographically, the company's revenue concentration data is not available in the current dataset. Segmental breakdowns also remain undisclosed, suggesting a lack of transparency in operational diversification. This opacity limits the ability to assess risk distribution across product lines or geographic markets. Looking ahead, the company faces a challenging growth trajectory. With no revenue growth data available and a current operating loss, the outlook for near-term profitability remains uncertain. Analysts have assigned a mean price target of $4.67, implying a 124% upside from the current market price of $2.13, but the absence of disclosed revenue growth metrics makes this target speculative. Risk factors include the company's negative equity position and operating cash flow deficit. The dilution risk is currently rated as low, with no immediate filing-based flags detected. However, the company's capital structure shows a debt-to-equity ratio of -1.47, indicating that liabilities exceed equity by a significant margin. Recent filings and transcripts do not show any material events that would significantly alter the company's risk profile. The absence of recent strategic announcements or product launches suggests a period of operational stability but also limited visibility into future growth drivers.
Business. Spectral AI Inc develops and commercializes AI-powered medical imaging solutions for diagnostic and therapeutic applications in healthcare.
Classification. The company is classified in the Healthcare sector under Advanced Medical Equipment & Technology with 92% confidence based on verified market data.
- The company maintains a cash buffer of $15.4 million but faces a liquidity risk due to $27.1 million in liabilities.
- Spectral AI's financial performance lags industry norms with a negative return on assets of -0.35%.
- Analysts project a mean price target of $4.67, implying a 124% upside from the current market price.
- The company's capital structure shows a debt-to-equity ratio of -1.47, indicating significant leverage.
- No immediate dilution or liquidity flags were detected in recent filings.
- --
- ## RATIONALES
- ```json
- No immediate filing-based liquidity or dilution flags were detected.